Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patients
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
- Latest
- Trending
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
"Discover why Bitcoin's price is down today: market declines, trader fatigue, and ETF outflows impacting the broader cryptocurrency market."
"HighPoint Advisor Group invests in Align Tech, joining other major investors. Analysts offer a moderate buy rating with potential future ...
Cyber hackers Qilin leak 400GB of NHS blood test data, including patient info and financial records, disrupting London hospitals and ...
Federal judge rules Biden-era policy against hospital web trackers as unlawful over HIPAA scope, impacting healthcare tech use.
Jazz Pharmaceuticals hits a hurdle as its essential tremor drug trial misses primary endpoint. Awaiting Parkinson's trial results for future ...
Esperion's stock downgraded by BofA due to rising competition from Merck's PCSK9 inhibitors. Analysts weigh in on efficacy and market ...
Maui Health Center allegedly attacked by Russian hackers, causing a major disruption. FalconFeeds identifies Lockbit group; FBI investigates.
Learn how to claim crypto airdrops using this simple guide. Explore steps, eligibility, secure procedures, and strategies to maximize rewards.
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.